Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tumor Electric Field Therapy Inhibits Epithelial-Mesenchymal Transition, Invasion, and Migration of Glioblastoma by Targeting the c-FOS/CXCL14 Axis.

CNS neuroscience & therapeutics·2026
Same author

Construction of Predictive Machine Learning Model of Glioma-Associated Gut Microbiota.

Brain and behavior·2025
Same author

Plasma-Derived Exosomal i-tRF-LeuCAA as Biomarker for Glioma Diagnosis and Promoter of Epithelial-Mesenchymal Transition via TPM4 Regulation.

CNS neuroscience & therapeutics·2025
Same author

Cold Inducible RNA-Binding Protein Promotes the Development of Alzheimer's Disease Partly by Inhibition of uPA in Astrocytes.

Degenerative neurological and neuromuscular disease·2025
Same author

EXPLORING THE POTENTIAL OF BEND7 AS AN IMMUNOMODULATORY BIOMARKER IN SEPSIS THROUGH INTEGRATIVE GENOMIC AND TRANSCRIPTOMIC ANALYSIS.

Shock (Augusta, Ga.)·2024
Same author

Leukocyte immunoglobulin-like receptor B4: A keystone in immune modulation and therapeutic target in cancer and beyond.

Cancer innovation·2024

相关实验视频

Updated: Jan 7, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.1K

瘤电场疗法抑制了质母细胞瘤中的TGF-β/C1R信号轴驱动的上皮-半细胞过渡

Junyi Chen1,2,3, Yuyang Liu4,5, Qi Liu1,6

  • 1Medical School of Chinese PLA, Beijing, China.

CNS neuroscience & therapeutics
|January 5, 2026
PubMed
概括

No abstract available in PubMed .

关键词:
一个EMTTGF-β信号通路补充 C1R质母细胞瘤中酶子类型瘤电场疗法

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K
Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma
11:02

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Published on: August 9, 2022

3.4K

相关实验视频

Last Updated: Jan 7, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.1K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K
Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma
11:02

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Published on: August 9, 2022

3.4K